HR 2351: To direct the Commandant of the Coast Guard to update the policy of the Coast Guard regarding the use of medication to treat drug overdose, and for other purposes.

HR 2351 in plain English: This bill requires the Coast Guard to make naloxone (an opioid overdose reversal medication) available at all its installations and in operational environments, and to join a Department of Defense system that tracks naloxone distribution and illegal controlled substance use. It also clarifies that laws banning controlled substances on vessels apply even when drugs are placed on board without the crew's knowledge, and requires the Coast Guard to brief Congress within two years on opioid use and overdose medication at its facilities.

Stated purpose

The bill directs the Coast Guard to update its policy so that naloxone (an opioid overdose reversal medication) is available at all Coast Guard installations and in every operational setting, and to join a Department of Defense tracking system for naloxone distribution and illegal controlled substance use.

Key points

• Requires naloxone or a similar overdose-reversal medication to be available at all Coast Guard installations and in operational settings.
• Directs the Coast Guard to join the Department of Defense tracking system for naloxone distribution and illegal use of fentanyl and other controlled substances.
• Requires the Coast Guard to finalize a memorandum of understanding with the Department of Defense to access the tracking system.
• Clarifies that laws banning controlled substances on vessels apply when drugs are placed on board without the crew's knowledge or on unmanned vessels.
• Mandates a briefing to Congress within two years on opioid use, overdose medication, and substance abuse mitigation at Coast Guard facilities.

Arguments supporters make

• Coast Guard members face real overdose risks, including from fentanyl encountered during drug interdiction operations, and having naloxone on hand could save lives in emergencies where medical help is far away.
• Joining the DOD tracking system gives leadership better data on substance abuse trends, allowing the Coast Guard to address problems before they grow and protect unit readiness.
• Clarifying that drug trafficking laws cover controlled substances placed on vessels without a crew's knowledge closes a potential legal loophole and strengthens enforcement against smugglers.

Arguments opponents make

• Making naloxone widely available across all installations may signal acceptance of drug use within the ranks rather than focusing resources on prevention and stricter enforcement of existing drug policies.
• Expanding the controlled substances law to cover unmanned or unknowing-crew scenarios could raise due process concerns if individuals are prosecuted based on actions they had no knowledge of or control over.
• Mandating new policies, tracking systems, and congressional briefings adds administrative burdens and costs to the Coast Guard without clear evidence that current access to overdose treatment is inadequate.

Tradeoffs

Broader naloxone access and data tracking may save lives and improve oversight, but involve increased administrative requirements and raise questions about how to balance harm reduction approaches with existing zero-tolerance drug policies in a military branch.

Current status in Congress: Passed House.